Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The medication reduces hunger, but it does not prevent you from overriding that signal
Wegovy is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or with overweight plus a weight-related condition
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes management, has emerged as a treatment option for chronic weight management in adults with obesity or overweight conditions
Animal studies showed that exposure to GLP1-RAs was associated with small-for-gestational age pups (birthweight that is lower than expected at the time of delivery), and there was an increased risk of birth defects compared to unexposed animals
Ozempic and Wegovy, powered by semaglutide, and Mounjaro, based on tirzepatide, have captured global attention
Dermatology Research and Practice, 2024 , 5551774.
